tert-Butyl 2-hydroxy-6-azaspiro[3.4]octane-6-carboxylate

Catalog No.: 
ACSBON196
CAS No.: 
1239319-91-5
Molecular Formula: 
C12H21NO3
Molecular Weight: 
227.30
tert-Butyl 2-hydroxy-6-azaspiro[3.4]octane-6-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%
25g98%
100g98%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 2-hydroxy-6-azaspiro[3.4]octane-6-carboxylate
IUPAC Nametert-butyl 2-hydroxy-6-azaspiro[3.4]octane-6-carboxylate
MDL No.MFCD18073249
Molecular FormulaC12H21NO3
Molecular Weight227.30
SMILESO=C(N(CC1)CC21CC(O)C2)OC(C)(C)C
InChI KeyKAVBYCOMZDNOFX-UHFFFAOYSA-N
Synonymtert-Butyl 2-hydroxy-6-azaspiro[3.4]octane-6-carboxylate | MFCD18073249 | 6-Boc-2-hydroxy-6-aza-spiro[3.4]octane | N-BOC-6-AZASPIRO[3.4]OCTAN-2-OL | 6-Boc-6-azaspiro[3.4]octan-2-ol
CAS No.1239319-91-5
PubChem CID69669842

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACSBON196 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKSPB825 route compound structure diagram
    ACKSPB825203661-71-6In Stock
  2. Then
  3. ACSBON196 route product structure diagram
    ACSBON1961239319-91-5In Stock
Inquiry

2. ACSBON196 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACECSI842 route compound structure diagram
    ACECSI8422027496-49-5In Stock
  4. Then
  5. ACSBON196 route product structure diagram
    ACSBON1961239319-91-5In Stock
Inquiry

3. ACSBON196 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSBON196 route product structure diagram
    ACSBON1961239319-91-5In Stock
Inquiry

Comments (0)